KBCT for Primary Screening
Breast Cancer Screening
Research / AspirationalActive
Key Facts
About Koning
Koning is a private medical device company that has developed an innovative breast imaging system, the Koning Vera Breast CT (KBCT). This device utilizes cone-beam CT technology to generate true 3D images of the breast in under 10 seconds without compression, at radiation doses comparable to diagnostic mammography. The company targets the significant limitations of standard mammography, particularly its high miss rates in dense breast tissue, with a goal of improving early detection and patient experience. Koning holds over 120 patents globally and is in the commercial rollout phase, placing devices in imaging centers worldwide.
View full company profileTherapeutic Areas
Other Breast Cancer Screening Drugs
| Drug | Company | Phase |
|---|---|---|
| BREASTEST plus™ | Bcal Diagnostics | Commercial |
| Auria | Namida Lab | Commercial |
| Non-Contrast Breast MRI Screening Research | Ikonopedia | Research |
| Electrical Mammogram | NovaScan | Pre-clinical |
| Thermalytix | Niramai | Approved |
| Breast Cancer Screening AI | Vara | Commercial |
| PRISM Randomized Controlled Trial | ScreenPoint Medical | Trial |